Nuvation Bio Inc.

NYSE: NUVB · Real-Time Price · USD
2.75
-0.01 (-0.36%)
At close: Aug 15, 2025, 2:34 PM

Nuvation Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
35.72M 42.65M 101.1M 132.42M
Short-Term Investments
466.97M 568.56M 559.91M 632.97M
Long-Term Investments
n/a n/a -559.36M n/a
Other Long-Term Assets
6.76M 728K 559.49M 421K
Receivables
16.29M 3.7M 2.48M 3.04M
Inventory
n/a n/a n/a n/a
Other Current Assets
7.27M 1.52M 3.82M n/a
Total Current Assets
526.25M 616.43M 667.32M 772.07M
Property-Plant & Equipment
2.99M 4.32M 4.68M 3.66M
Goodwill & Intangibles
4.62M n/a n/a n/a
Total Long-Term Assets
14.37M 5.05M 4.82M 4.08M
Total Assets
540.63M 621.48M 672.14M 776.15M
Account Payables
6.35M 2.21M 2.14M 3.92M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
6.28M n/a n/a n/a
Other Current Liabilities
17.34M 4.35M 2.78M 5.3M
Total Current Liabilities
58.24M 13.97M 13.16M 16.93M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
2.05M 353K 850K 11.04M
Total Long-Term Liabilities
18.59M 2.39M 3.9M 13.23M
Total Liabilities
76.84M 16.36M 17.07M 30.15M
Total Debt
8.91M 4.01M 4.26M 3.06M
Common Stock
1.37B 947.75M 927.6M 909.99M
Retained Earnings
-910.74M -342.8M -267M -162.8M
Comprehensive Income
573K 181K -5.53M -1.19M
Shareholders Equity
463.79M 605.12M 655.08M 746M
Total Investments
466.97M 568.56M 559.91K 632.97M